Powered by 
Translate
Translate
Diaceutics - Notice of Results & Presentations
New York, Belfast and London, 11 September 2025 - Diaceutics PLC (AIM: DXRX), a leading technology and solutions provider to the pharma and biotech industry, will announce its unaudited results for the half year ended 30 June 2025 on Tuesday, 23 September 2025.
Analyst & Investor Presentation:
A webinar presentation for analysts and investors will be held at 1430 BST (0930 EDT) on Tuesday, 23 September 2025. Those wishing to attend can register their interest using the following link:
https://us06web.zoom.us/webinar/register/WN_lcoB0C3eSc20_DCSsisB5A
Enquiries:
|
Diaceutics PLC |
|
|
Ryan Keeling, Chief Executive Officer Nick Roberts, Chief Financial Officer |
Tel: +44 (0)28 9040 6500 investorrelations@diaceutics.com
|
|
|
|
|
Canaccord Genuity Limited (Nomad & Broker) |
Tel: +44 (0)20 7523 8000 |
|
Simon Bridges, Andrew Potts, Harry Rees |
|
About Diaceutics
At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostics Network ®.
